Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Personalized Medicine

PUBLISHER: Visiongain | PRODUCT CODE: 1790694

Cover Image

PUBLISHER: Visiongain | PRODUCT CODE: 1790694

Precision Medicine Market Report 2025-2035

PUBLISHED:
PAGES: 463 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User) - 1 Year License
USD 5872.50
PDF (Team License - Up to 6 Users) - 1 Year License
USD 6952.50
PDF (Site License)
USD 8167.50
PDF (Enterprise License - Includes Free Datasets)
USD 10320.75

Add to Cart

Description

Table of Contents

List of Tables

The global Precision Medicine market is projected to grow at a CAGR of 15.1% by 2035

The Precision Medicine Market Report 2025-2035 (Including Impact of U.S. Trade Tariffs): This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

The Increasing Adoption of Targeted Therapies is Driving Market Growth

The growing focus on treatments customised to each patient's unique characteristics is driving substantial growth in the precision medicine market, supported by the demand for more effective, personalised therapies with fewer adverse effects. With increasing cases of cancer, rare genetic disorders, and chronic diseases, biomarker-based therapies and companion diagnostics are proving highly impactful. This has led to greater investment from pharma companies and research institutions in developing treatments tailored to individual genetic profiles.

For instance, on November 27, 2024, the European Commission granted approval for Novartis' Kisqali to treat a broader population of patients with hormone receptor-positive (HR+), HER2-negative early-stage breast cancer who face a high risk of recurrence. These approvals highlight the rising focus on genetically guided treatments, set to transform the precision medicine landscape by enhancing survival rates and patient outcomes. With ongoing advances in genomic sequencing, AI-driven analytics, and liquid biopsy technologies, the demand for targeted therapies is expected to grow rapidly, solidifying precision medicine as a key pillar of future healthcare.

Lack of Interoperability Across Healthcare Data Systems Is Likely to Hinder Market Growth

One of the key barriers to realizing the full potential of precision medicine is the lack of interoperability across healthcare data systems. Precision medicine depends on the seamless integration of genomic data, electronic health records (EHRs), real-world evidence, and biomarker insights but fragmented data sources hinder this process. Without standardized frameworks for data sharing, clinicians, researchers, and pharma companies face difficulties in accessing and utilizing patient-specific information effectively.

For instance, genomic data from sequencing platforms often don't align with hospital EHR systems, limiting physicians' ability to make informed treatment decisions. Patients receiving care from multiple providers may also experience fragmented records, reducing the effectiveness of personalized therapies. This data disconnect extends to pharmaceutical R&D, where incomplete datasets slow down biomarker discovery and clinical trials. Overcoming these challenges calls for standardized data exchange protocols, AI-powered integration tools, and stronger collaboration among healthcare providers, tech developers, and regulators to drive progress in precision medicine.

What would be the Impact of the U.S. Trade Tariffs on the Global Precision Medicine Market?

The impact of the U.S. trade tariffs extends beyond production to the accessibility and affordability of precision medicine solutions for patients. As manufacturers pass increased costs down the supply chain, hospitals and clinics may be forced to charge more for advanced genomic tests, targeted therapies, and personalised diagnostics services that are already relatively expensive. This price inflation risks widening the healthcare gap, making precision medicine even less accessible in underfunded or rural healthcare systems, both in the U.S. and abroad. In countries that rely heavily on the U.S.-based technologies or partnerships, these disruptions could delay the adoption of new medical innovations, particularly those tailored to specific genetic or regional population needs.

The precision medicine market thrives on global collaboration among researchers, data scientists, and clinicians across borders, who often share genomic datasets, clinical trial resources, and AI-based diagnostic tools. Trade tensions and tariffs can create a ripple effect, weakening international research alliances and data-sharing efforts due to increased compliance barriers, licensing issues, or protectionist policies.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the precision medicine market evolving?
  • What is driving and restraining the precision medicine market?
  • How will each precision medicine submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2035?
  • How will the market shares for each precision medicine submarket develop from 2025 to 2035?
  • What will be the main driver for the overall market from 2025 to 2035?
  • Will leading precision medicine markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2035 and which geographical region will lead the market in 2035?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the precision medicine projects for these leading companies?
  • How will the industry evolve during the period between 2025 and 2035? What are the implications of precision medicine projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the precision medicine market?
  • Where is the precision medicine market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the precision medicine market today, and over the next 10 years:

  • Our 463-page report provides 187 tables, 293 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them - NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.
  • Forecasts to 2035 and other analysis reveal commercial prospects
  • In addition to revenue forecasting to 2035, our new study provides you with recent results, growth rates, and market shares.
  • You will find original analysis, with business outlooks and developments.
  • Discover qualitative analysis (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising precision medicine prices and recent developments.

Segments Covered in the Report

  • Product
  • Therapeutics
  • Monoclonal Antibodies
  • Inhibitor Drugs
  • Cell & Gene Therapies
  • RNA-Based Therapies
  • Others
  • Diagnostics
  • Genetic Tests
  • Biomarker-based Tests
  • Other Diagnostic Tests
  • Application
  • Oncology
  • Immunology
  • CNS
  • Respiratory
  • Others
  • Technology
  • Gene Sequencing
  • Drug Discovery
  • Big Data Analytics
  • Companion Diagnostics
  • Bioinformatics
  • Other Technologies
  • End-users
  • Hospitals
  • Diagnostic Centers
  • Research & Academic Institutes
  • Other End-users

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 25 leading national markets:

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Singapore
  • Thailand
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of Latin America
  • MEA
  • GCC
  • South Africa
  • Rest of MEA

The report also includes profiles and for some of the leading companies in the Precision Medicine Market, 2025 to 2035, with a focus on this segment of these companies' operations.

  • Leading companies profiled in the report
  • 23andMe, Inc.
  • Abbott
  • Abnova Corporation
  • Adaptive Biotechnologies
  • Agilent Technologies Inc.
  • AstraZeneca
  • Bayer AG
  • Biogen
  • bioMerieux SA
  • Bristol-Myers Squibb Company
  • Bruker Corporation
  • Danaher
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • GE HealthCare
  • GRAIL Inc.
  • GSK plc
  • Illumina, Inc.
  • Johnson & Johnson
  • Laboratory Corporation of America Holdings
  • Myriad Genetics Inc
  • Novartis AG
  • Pfizer Inc.
  • Qiagen
  • Quest Diagnostics Incorporated
  • Regeneron Pharmaceuticals
  • Tempus
  • Teva Pharmaceutical Industries Ltd.

Overall world revenue for Precision Medicine Market, 2025 to 2035 in terms of value the market will surpass US$150 billion in 2025, our work calculates. We predict strong revenue growth through to 2035. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

  • How will the Precision Medicine Market, 2025 to 2035 report help you?
  • In summary, our 460+ page report provides you with the following knowledge:
  • Revenue forecasts to 2035 for Precision Medicine Market, 2025 to 2035, with forecasts for product, application, technology, and end-user, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2035 for five regional and 25 key national markets - See forecasts for the Precision Medicine Market, 2025 to 2035 in North America, Europe, Asia Pacific, Latin America, and MEA. Also forecasted is the market in the U.S., Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 28 of the major companies involved in the Precision Medicine Market, 2025 to 2035.
  • Find quantitative and qualitative analysis with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Show more
Product Code: PHA1351

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Precision Medicine Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 Who is This Report for?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
  • 3.3 Impact Analysis
    • 3.3.1 Market Driving Factors
      • 3.3.1.1 Increasing Global Burden of Cancer Boosts the Demand for Personalized Medicine
      • 3.3.1.2 Increase in Scope of Application of Precision Medicine
      • 3.3.1.3 Accelerating Demand for Targeted Therapy
      • 3.3.1.4 Growing Precedence of Precision Medicine Over Traditional Practice of ,AuOne-Size-Fits-All,Au Therapies
    • 3.3.2 Market Restraining Factors
      • 3.3.2.1 High Cost of Precision Medicine
      • 3.3.2.2 Lack of Data Interoperability
      • 3.3.2.3 Insufficient Funding for Diagnostics Space in the Emerging Economies
    • 3.3.3 Market Opportunities
      • 3.3.3.1 Growing Use of AI in Healthcare is Boosting Demand for Precision Medicine
      • 3.3.3.2 Growing Acceptance of Gene Therapy and Gene Editing Technology
  • 3.4 U.S. Tariffs: What's the Impact on Global Precision Medicine Market?
    • 3.4.1 Overview
    • 3.4.2 V-Shaped Recovery Scenario
      • 3.4.2.1 Why V-Shaped Recovery?
      • 3.4.2.2 Impact from Tariffs
      • 3.4.2.3 Market Dynamics and Demand Recovery
      • 3.4.2.4 Policy and Funding Support
      • 3.4.2.5 Timeframe for Recovery
    • 3.4.3 U-Shaped Recovery Scenario
      • 3.4.3.1 Why U-Shaped Recovery?
      • 3.4.3.2 Impact from Tariffs
      • 3.4.3.3 Market Dynamics and Demand Recovery
      • 3.4.3.4 Policy and Funding Support
      • 3.4.3.5 Timeframe for Recovery
    • 3.4.4 L Shaped Recovery Scenario
      • 3.4.4.1 Why L-Shaped Recovery?
      • 3.4.4.2 Impact from Tariffs
      • 3.4.4.3 Market Dynamics and Demand Recovery
      • 3.4.4.4 Policy and Funding Support
      • 3.4.4.5 Timeframe for Recovery
    • 3.4.5 What Strategic Considerations Should Clients Factor into Their Near-term (2025-2030) and Long-term (2025-2035) Planning?
    • 3.4.6 Impact of U.S. and China Trade War on Precision Medicine Market
    • 3.4.7 How Might the Most Impacted Countries Experience Positive and Negative Effects Resulting from These Policy Changes?
    • 3.4.8 Global Market Tariff Sensitivity and Margin Pressure Analysis
  • 3.5 Porter's Five Forces Analysis
    • 3.5.1 Bargaining Power of Supplier
    • 3.5.2 Bargaining Power of Buyers
    • 3.5.3 Threat of New Entrants
    • 3.5.4 Threat of Substitutes
    • 3.5.5 Competitive Rivalry
  • 3.6 SWOT Analysis
  • 3.7 PEST Analysis

4 Precision Medicine Market Analysis by Product Type

  • 4.1 Key Findings
  • 4.2 Product Type Segment: Market Attractiveness Index
  • 4.3 Precision Medicine Market Size Estimation and Forecast by Product Type
  • 4.4 Therapeutics
    • 4.4.1 Therapeutics Segment: Market Attractiveness Index
    • 4.4.2 Therapeutics Market Size Estimation and Forecast by Type
    • 4.4.3 Market Size by Region, 2025-2035 (US$ Billion)
    • 4.4.4 Market Share by Region, 2025 & 2035 (%)
    • 4.4.5 Monoclonal Antibodies
      • 4.4.5.1 Market Size by Region, 2025-2035 (US$ Billion)
      • 4.4.5.2 Market Share by Region, 2025 & 2035 (%)
    • 4.4.6 Inhibitor Drugs
      • 4.4.6.1 Market Size by Region, 2025-2035 (US$ Billion)
      • 4.4.6.2 Market Share by Region, 2025 & 2035 (%)
    • 4.4.7 Cell & Gene Therapies
      • 4.4.7.1 Market Size by Region, 2025-2035 (US$ Billion)
      • 4.4.7.2 Market Share by Region, 2025 & 2035 (%)
    • 4.4.8 RNA-Based Therapies
      • 4.4.8.1 Market Size by Region, 2025-2035 (US$ Billion)
      • 4.4.8.2 Market Share by Region, 2025 & 2035 (%)
    • 4.4.9 Others
      • 4.4.9.1 Market Size by Region, 2025-2035 (US$ Billion)
      • 4.4.9.2 Market Share by Region, 2025 & 2035 (%)
  • 4.5 Diagnostics
    • 4.5.1 Diagnostics Segment: Market Attractiveness Index
    • 4.5.2 Diagnostics Market Size Estimation and Forecast by Type
    • 4.5.3 Market Size by Region, 2025-2035 (US$ Billion)
    • 4.5.4 Market Share by Region, 2025 & 2035 (%)
    • 4.5.5 Genetic Tests
      • 4.5.5.1 Market Size by Region, 2025-2035 (US$ Billion)
      • 4.5.5.2 Market Share by Region, 2025 & 2035 (%)
    • 4.5.6 Biomarker-based Tests
      • 4.5.6.1 Market Size by Region, 2025-2035 (US$ Billion)
      • 4.5.6.2 Market Share by Region, 2025 & 2035 (%)
    • 4.5.7 Others
      • 4.5.7.1 Market Size by Region, 2025-2035 (US$ Billion)
      • 4.5.7.2 Market Share by Region, 2025 & 2035 (%)

5 Precision Medicine Market, by Application, 2025-2035

  • 5.1 Key Findings
  • 5.2 Application Segment: Market Attractiveness Index
  • 5.3 Precision Medicine Market Size Estimation and Forecast by Application
  • 5.4 Oncology
    • 5.4.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 5.4.2 Market Share by Region, 2025 & 2035 (%)
  • 5.5 Immunology
    • 5.5.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 5.5.2 Market Share by Region, 2025 & 2035 (%)
  • 5.6 CNS
    • 5.6.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 5.6.2 Market Share by Region, 2025 & 2035 (%)
  • 5.7 Respiratory
    • 5.7.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 5.7.2 Market Share by Region, 2025 & 2035 (%)
  • 5.8 Others
    • 5.8.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 5.8.2 Market Share by Region, 2025 & 2035 (%)

6 Precision Medicine Market, by Technology, 2025-2035

  • 6.1 Key Findings
  • 6.2 Technology Segment: Market Attractiveness Index
  • 6.3 Precision Medicine Market Size Estimation and Forecast by Technology
  • 6.4 Gene Sequencing
    • 6.4.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 6.4.2 Market Share by Region, 2025 & 2035 (%)
  • 6.5 Drug Discovery
    • 6.5.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 6.5.2 Market Share by Region, 2025 & 2035 (%)
  • 6.6 Big Data Analytics
    • 6.6.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 6.6.2 Market Share by Region, 2025 & 2035 (%)
  • 6.7 Companion Diagnostics
    • 6.7.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 6.7.2 Market Share by Region, 2025 & 2035 (%)
  • 6.8 Bioinformatics
    • 6.8.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 6.8.2 Market Share by Region, 2025 & 2035 (%)
  • 6.9 Other Technologies
    • 6.9.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 6.9.2 Market Share by Region, 2025 & 2035 (%)

7 Precision Medicine Market, by End-users, 2025-2035

  • 7.1 Key Findings
  • 7.2 End-users Segment: Market Attractiveness Index
  • 7.3 Precision Medicine Market Size Estimation and Forecast by End-users
  • 7.4 Hospitals
    • 7.4.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 7.4.2 Market Share by Region, 2025 & 2035 (%)
  • 7.5 Diagnostic Centres
    • 7.5.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 7.5.2 Market Share by Region, 2025 & 2035 (%)
  • 7.6 Research & Academic Institutes
    • 7.6.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 7.6.2 Market Share by Region, 2025 & 2035 (%)
  • 7.7 Other End-users
    • 7.7.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 7.7.2 Market Share by Region, 2025 & 2035 (%)

8 Precision Medicine Market Analysis by Region

  • 8.1 Key Findings
  • 8.2 Regional Market Size Estimation and Forecast

9 North America Precision Medicine Market Analysis

  • 9.1 Key Findings
  • 9.2 North America Precision Medicine Market Attractiveness Index
  • 9.3 North America Precision Medicine Market Size by Country, 2025, 2030 & 2035 (US$ Billion)
  • 9.4 North America Precision Medicine Market Size Estimation and Forecast by Country
  • 9.5 North America Precision Medicine Market Size Estimation and Forecast by Product Type
    • 9.5.1 North America Therapeutics Market Size Estimation and Forecast by Type
    • 9.5.2 North America Diagnostics Market Size Estimation and Forecast by Type
  • 9.6 North America Precision Medicine Market Size Estimation and Forecast by Application
  • 9.7 North America Precision Medicine Market Size Estimation and Forecast by Technology
  • 9.8 North America Precision Medicine Market Size Estimation and Forecast by End-users
  • 9.9 U.S. Precision Medicine Market Analysis
  • 9.10 Canada Precision Medicine Market Analysis

10 Europe Precision Medicine Market, 2025-2035

  • 10.1 Key Findings
  • 10.2 Europe Precision Medicine Market Attractiveness Index
  • 10.3 Europe Precision Medicine Market by Country, 2025, 2030 & 2035 (US$ Billion)
  • 10.4 Europe Precision Medicine Market Size Estimation and Forecast by Country
  • 10.5 Europe Precision Medicine Market Size Estimation and Forecast by Product Type
    • 10.5.1 Europe Therapeutics Market Size Estimation and Forecast by Type
    • 10.5.2 Europe Diagnostics Market Size Estimation and Forecast by Type
  • 10.6 Europe Precision Medicine Market Size Estimation and Forecast by Application
  • 10.7 Europe Precision Medicine Market Size Estimation and Forecast by Technology
  • 10.8 Europe Precision Medicine Market Size Estimation and Forecast by End-users
  • 10.9 Germany Precision Medicine Market Analysis
  • 10.10 UK Precision Medicine Market Analysis
  • 10.11 France Precision Medicine Market Analysis
  • 10.12 Italy Precision Medicine Market Analysis
  • 10.13 Spain Precision Medicine Market Analysis
  • 10.14 Russia Precision Medicine Market Analysis
  • 10.15 Netherlands Precision Medicine Market Analysis
  • 10.16 Denmark Precision Medicine Market Analysis
  • 10.17 Rest of Europe Precision Medicine Market Analysis

11 Asia Pacific Precision Medicine Market Analysis

  • 11.1 Key Findings
  • 11.2 Asia Pacific Precision Medicine Market Attractiveness Index
  • 11.3 Asia Pacific Precision Medicine Market by Country, 2025, 2030 & 2035 (US$ Billion)
  • 11.4 Asia Pacific Precision Medicine Market Size Estimation and Forecast by Country
  • 11.5 Asia Pacific Precision Medicine Market Size Estimation and Forecast by Product Type
    • 11.5.1 Asia Pacific Therapeutics Market Size Estimation and Forecast by Type
    • 11.5.2 Asia Pacific Diagnostics Market Size Estimation and Forecast by Type
  • 11.6 Asia Pacific Precision Medicine Market Size Estimation and Forecast by Application
  • 11.7 Asia Pacific Precision Medicine Market Size Estimation and Forecast by Technology
  • 11.8 Asia Pacific Precision Medicine Market Size Estimation and Forecast by End-users
  • 11.9 Japan Precision Medicine Market Analysis
  • 11.10 China Precision Medicine Market Analysis
  • 11.11 India Precision Medicine Market Analysis
  • 11.12 Australia Precision Medicine Market Analysis
  • 11.13 South Korea Precision Medicine Market Analysis
  • 11.14 Singapore Precision Medicine Market Analysis
  • 11.15 Thailand Precision Medicine Market Analysis
  • 11.16 Rest of Asia Pacific Precision Medicine Market Analysis

12 Latin America Precision Medicine Market Analysis

  • 12.1 Key Findings
  • 12.2 Latin America Precision Medicine Market Attractiveness Index
  • 12.3 Latin America Precision Medicine Market Size by Country, 2025, 2030 & 2035 (US$ Billion)
  • 12.4 Latin America Precision Medicine Market Size Estimation and Forecast by Country
  • 12.5 Latin America Precision Medicine Market Size Estimation and Forecast by Product Type
    • 12.5.1 Latin America Therapeutics Market Size Estimation and Forecast by Type
    • 12.5.2 Latin America Diagnostics Market Size Estimation and Forecast by Type
  • 12.6 Latin America Precision Medicine Market Size Estimation and Forecast by Application
  • 12.7 Latin America Precision Medicine Market Size Estimation and Forecast by Technology
  • 12.8 Latin America Precision Medicine Market Size Estimation and Forecast by End-users
  • 12.9 Brazil Precision Medicine Market Analysis
  • 12.10 Mexico Precision Medicine Market Analysis
  • 12.11 Argentina Precision Medicine Market Analysis
  • 12.12 Colombia Precision Medicine Market Analysis
  • 12.13 Rest of Latin America Precision Medicine Market Analysis

13 MEA Precision Medicine Market Analysis

  • 13.1 Key Findings
  • 13.2 MEA Precision Medicine Market Attractiveness Index
  • 13.3 MEA Precision Medicine Market Size by Country, 2025, 2030 & 2035 (US$ Billion)
  • 13.4 MEA Precision Medicine Market Size Estimation and Forecast by Country
  • 13.5 MEA Precision Medicine Market Size Estimation and Forecast by Product Type
    • 13.5.1 MEA Therapeutics Market Size Estimation and Forecast by Type
    • 13.5.2 MEA Diagnostics Market Size Estimation and Forecast by Type
  • 13.6 MEA Precision Medicine Market Size Estimation and Forecast by Application
  • 13.7 MEA Precision Medicine Market Size Estimation and Forecast by Technology
  • 13.8 MEA Precision Medicine Market Size Estimation and Forecast by End-users
  • 13.9 GCC Precision Medicine Market Analysis
  • 13.10 South Africa Precision Medicine Market Analysis
  • 13.11 Egypt Precision Medicine Market Analysis
  • 13.12 Rest of MEA Precision Medicine Market Analysis

14 Company Profiles

  • 14.1 Competitive Landscape, 2024
  • 14.2 Pfizer Inc.
    • 14.2.1 Company Snapshot
    • 14.2.2 Company Overview
    • 14.2.3 Financial Analysis
      • 14.2.3.1 Net Revenue, 2020-2024
      • 14.2.3.2 R&D, 2020-2024
      • 14.2.3.3 Regional Market Shares, 2024
      • 14.2.3.4 Business Market Shares, 2024
    • 14.2.4 Product Benchmarking
    • 14.2.5 Strategic Outlook
    • 14.2.6 SWOT Analysis
  • 14.3 Qiagen
    • 14.3.1 Company Snapshot
    • 14.3.2 Company Overview
    • 14.3.3 Financial Analysis
      • 14.3.3.1 Net Revenue, 2020-2024
      • 14.3.3.2 R&D, 2020-2024
      • 14.3.3.3 Regional Market Shares, 2024
      • 14.3.3.4 Business Market Shares, 2024
    • 14.3.4 Product Benchmarking
    • 14.3.5 Strategic Outlook
  • 14.4 Quest Diagnostics Incorporated
    • 14.4.1 Company Snapshot
    • 14.4.2 Company Overview
    • 14.4.3 Financial Analysis
      • 14.4.3.1 Net Revenue, 2020-2024
    • 14.4.4 Product Benchmarking
    • 14.4.5 Strategic Outlook
  • 14.5 Agilent Technologies Inc.
    • 14.5.1 Company Snapshot
    • 14.5.2 Company Overview
    • 14.5.3 Financial Analysis
      • 14.5.3.1 Net Revenue, 2020-2024
      • 14.5.3.2 R&D, 2020-2024
      • 14.5.3.3 Regional Market Shares, 2024
      • 14.5.3.4 Business Market Shares, 2024
    • 14.5.4 Product Benchmarking
    • 14.5.5 Strategic Outlook
  • 14.6 Illumina, Inc.
    • 14.6.1 Company Snapshot
    • 14.6.2 Company Overview
    • 14.6.3 Financial Analysis
      • 14.6.3.1 Net Revenue, 2020-2024
      • 14.6.3.2 R&D, 2020-2024
      • 14.6.3.3 Regional Market Shares, 2024
    • 14.6.4 Product Benchmarking
    • 14.6.5 Strategic Outlook
  • 14.7 Novartis AG
    • 14.7.1 Company Snapshot
    • 14.7.2 Company Overview
    • 14.7.3 Financial Analysis
      • 14.7.3.1 Net Revenue, 2020-2024
      • 14.7.3.2 R&D, 2020-2024
      • 14.7.3.3 Regional Market Shares, 2024
    • 14.7.4 Product Benchmarking
    • 14.7.5 Strategic Outlook
    • 14.7.6 SWOT Analysis
  • 14.8 bioMerieux SA
    • 14.8.1 Company Snapshot
    • 14.8.2 Company Overview
    • 14.8.3 Financial Analysis
      • 14.8.3.1 Net Revenue, 2020-2024
      • 14.8.3.2 R&D, 2020-2024
      • 14.8.3.3 Regional Market Shares, 2024
    • 14.8.4 Product Benchmarking
    • 14.8.5 Strategic Outlook
  • 14.9 F. Hoffmann-La Roche Ltd
    • 14.9.1 Company Snapshot
    • 14.9.2 Company Overview
    • 14.9.3 Financial Analysis
      • 14.9.3.1 Net Revenue, 2020-2024
      • 14.9.3.2 R&D, 2020-2024
      • 14.9.3.3 Regional Market Shares, 2024
    • 14.9.4 Product Benchmarking
    • 14.9.5 Strategic Outlook
    • 14.9.6 SWOT Analysis
  • 14.10 Abbott
    • 14.10.1 Company Snapshot
    • 14.10.2 Company Overview
    • 14.10.3 Financial Analysis
      • 14.10.3.1 Net Revenue, 2020-2024
      • 14.10.3.2 R&D, 2020-2024
      • 14.10.3.3 Regional Market Shares, 2024
      • 14.10.3.4 Business Market Shares, 2024
    • 14.10.4 Product Benchmarking
    • 14.10.5 Strategic Outlook
  • 14.11 Eli Lilly and Company
    • 14.11.1 Company Snapshot
    • 14.11.2 Company Overview
    • 14.11.3 Financial Analysis
      • 14.11.3.1 Net Revenue, 2020-2024
      • 14.11.3.2 R&D, 2020-2024
      • 14.11.3.3 Regional Market Shares, 2024
    • 14.11.4 Product Benchmarking
    • 14.11.5 Strategic Outlook
  • 14.12 Thermo Fisher Scientific Inc.
    • 14.12.1 Company Snapshot
    • 14.12.2 Company Overview
    • 14.12.3 Financial Analysis
      • 14.12.3.1 Net Revenue, 2020-2024
      • 14.12.3.2 R&D, 2020-2024
      • 14.12.3.3 Regional Market Shares, 2024
    • 14.12.4 Product Benchmarking
    • 14.12.5 Strategic Outlook
  • 14.13 AstraZeneca
    • 14.13.1 Company Snapshot
    • 14.13.2 Company Overview
    • 14.13.3 Financial Analysis
      • 14.13.3.1 Net Revenue, 2020-2024
      • 14.13.3.2 R&D, 2020-2024
      • 14.13.3.3 Regional Market Shares, 2024
      • 14.13.3.4 Business Market Shares, 2024
    • 14.13.4 Product Benchmarking
    • 14.13.5 Strategic Outlook
  • 14.14 Myriad Genetics Inc
    • 14.14.1 Company Snapshot
    • 14.14.2 Company Overview
    • 14.14.3 Financial Analysis
      • 14.14.3.1 Net Revenue, 2020-2024
      • 14.14.3.2 R&D, 2020-2024
      • 14.14.3.3 Regional Market Shares, 2024
      • 14.14.3.4 Business Market Shares, 2024
    • 14.14.4 Product Benchmarking
    • 14.14.5 Strategic Outlook
  • 14.15 GSK plc
    • 14.15.1 Company Snapshot
    • 14.15.2 Company Overview
    • 14.15.3 Financial Analysis
      • 14.15.3.1 Net Revenue, 2020-2024
      • 14.15.3.2 R&D, 2020-2024
      • 14.15.3.3 Regional Market Shares, 2024
      • 14.15.3.4 Business Market Shares, 2024
    • 14.15.4 Product Benchmarking
    • 14.15.5 Strategic Outlook
    • 14.15.6 SWOT Analysis
  • 14.16 Bristol-Myers Squibb Company
    • 14.16.1 Company Snapshot
    • 14.16.2 Company Overview
    • 14.16.3 Financial Analysis
      • 14.16.3.1 Net Revenue, 2020-2024
      • 14.16.3.2 R&D, 2020-2024
      • 14.16.3.3 Regional Market Shares, 2024
    • 14.16.4 Product Benchmarking
    • 14.16.5 Strategic Outlook
  • 14.17 Danaher
    • 14.17.1 Company Snapshot
    • 14.17.2 Company Overview
    • 14.17.3 Financial Analysis
      • 14.17.3.1 Net Revenue, 2020-2024
      • 14.17.3.2 R&D, 2020-2024
      • 14.17.3.3 Regional Market Shares, 2024
      • 14.17.3.4 Business Market Shares, 2024
    • 14.17.4 Product Benchmarking
    • 14.17.5 Strategic Outlook
  • 14.18 Laboratory Corporation of America Holdings
    • 14.18.1 Company Snapshot
    • 14.18.2 Company Overview
    • 14.18.3 Financial Analysis
      • 14.18.3.1 Net Revenue, 2020-2024
      • 14.18.3.2 Regional Market Shares, 2024
    • 14.18.4 Product Benchmarking
    • 14.18.5 Strategic Outlook
  • 14.19 GE HealthCare
    • 14.19.1 Company Snapshot
    • 14.19.2 Company Overview
    • 14.19.3 Financial Analysis
      • 14.19.3.1 Net Revenue, 2020-2024
      • 14.19.3.2 R&D, 2020-2024
      • 14.19.3.3 Regional Market Shares, 2024
    • 14.19.4 Product Benchmarking
    • 14.19.5 Strategic Outlook
  • 14.20 Teva Pharmaceutical Industries Ltd.
    • 14.20.1 Company Snapshot
    • 14.20.2 Company Overview
    • 14.20.3 Financial Analysis
      • 14.20.3.1 Net Revenue, 2020-2024
      • 14.20.3.2 R&D, 2020-2024
      • 14.20.3.3 Regional Market Shares, 2024
      • 14.20.3.4 Business Market Shares, 2024
    • 14.20.4 Product Benchmarking
    • 14.20.5 Strategic Outlook
  • 14.21 Bayer AG
    • 14.21.1 Company Snapshot
    • 14.21.2 Company Overview
    • 14.21.3 Financial Analysis
      • 14.21.3.1 Net Revenue, 2020-2024
      • 14.21.3.2 R&D, 2020-2024
      • 14.21.3.3 Regional Market Shares, 2024
      • 14.21.3.4 Business Market Shares, 2024
    • 14.21.4 Product Benchmarking
    • 14.21.5 Strategic Outlook
  • 14.22 Biogen
    • 14.22.1 Company Snapshot
    • 14.22.2 Company Overview
    • 14.22.3 Financial Analysis
      • 14.22.3.1 Net Revenue, 2020-2024
      • 14.22.3.2 R&D, 2020-2024
      • 14.22.3.3 Business Market Shares, 2024
    • 14.22.4 Product Benchmarking
    • 14.22.5 Strategic Outlook
  • 14.23 Johnson & Johnson
    • 14.23.1 Company Snapshot
    • 14.23.2 Company Overview
    • 14.23.3 Financial Analysis
      • 14.23.3.1 Net Revenue, 2020-2024
      • 14.23.3.2 R&D, 2020-2024
      • 14.23.3.3 Regional Market Shares, 2024
      • 14.23.3.4 Business Market Shares, 2024
    • 14.23.4 Product Benchmarking
    • 14.23.5 Strategic Outlook
    • 14.23.6 SWOT Analysis
  • 14.24 Abnova Corporation
    • 14.24.1 Company Snapshot
    • 14.24.2 Company Overview
    • 14.24.3 Product Benchmarking
    • 14.24.4 Strategic Outlook
  • 14.25 Bruker Corporation
    • 14.25.1 Company Snapshot
    • 14.25.2 Company Overview
    • 14.25.3 Financial Analysis
      • 14.25.3.1 Net Revenue, 2020-2024
      • 14.25.3.2 R&D, 2020-2024
      • 14.25.3.3 Regional Market Shares, 2024
      • 14.25.3.4 Business Market Shares, 2024
    • 14.25.4 Product Benchmarking
    • 14.25.5 Strategic Outlook
  • 14.26 23andMe, Inc.
    • 14.26.1 Company Snapshot
    • 14.26.2 Company Overview
    • 14.26.3 Financial Analysis
      • 14.26.3.1 Net Revenue, 2020-2024
      • 14.26.3.2 R&D, 2020-2024
      • 14.26.3.3 Regional Market Shares, 2024
      • 14.26.3.4 Business Market Shares, 2024
    • 14.26.4 Product Benchmarking
    • 14.26.5 Strategic Outlook
  • 14.27 Tempus
    • 14.27.1 Company Snapshot
    • 14.27.2 Company Overview
    • 14.27.3 Product Benchmarking
    • 14.27.4 Strategic Outlook
  • 14.28 GRAIL Inc.
    • 14.28.1 Company Snapshot
    • 14.28.2 Company Overview
    • 14.28.3 Financial Analysis
      • 14.28.3.1 Net Revenue, 2021-2024
      • 14.28.3.2 Regional Market Shares, 2024
      • 14.28.3.3 Business Market Shares, 2024
    • 14.28.4 Product Benchmarking
    • 14.28.5 Strategic Outlook
  • 14.29 Adaptive Biotechnologies
    • 14.29.1 Company Snapshot
    • 14.29.2 Company Overview
    • 14.29.3 Financial Analysis
      • 14.29.3.1 Net Revenue, 2020-2024
      • 14.29.3.2 R&D, 2020-2024
      • 14.29.3.3 Business Market Shares, 2024
    • 14.29.4 Product Benchmarking
    • 14.29.5 Strategic Outlook
  • 14.30 Regeneron Pharmaceuticals
    • 14.30.1 Company Snapshot
    • 14.30.2 Company Overview
    • 14.30.3 Financial Analysis
      • 14.30.3.1 Net Revenue, 2020-2024
      • 14.30.3.2 R&D, 2020-2024
      • 14.30.3.3 Business Market Shares, 2024
    • 14.30.4 Product Benchmarking
    • 14.30.5 Strategic Outlook

15 Conclusion and Recommendations

  • 15.1 Concluding Remarks from Visiongain
  • 15.2 Recommendations for Market Players
Show more
Product Code: PHA1351

List of Tables

  • Table 1 Precision Medicine Market Snapshot, 2025 & 2035 (US$ Billion, CAGR %)
  • Table 2 Precision Medicine Market: International Trade Tariff Impact Recovery Scenarios Snapshot
  • Table 3 Precision Medicine Market Forecast by Region 2025-2035 (US$ Million, AGR%, CAGR%), Tariff Impact: V- Shaped Recovery Scenario
  • Table 4 Precision Medicine Market Forecast by Region 2025-2035 (US$ Million, AGR%, CAGR%), Tariff Impact: U- Shaped Recovery Scenario
  • Table 5 Precision Medicine Market Forecast by Region 2025-2035 (US$ Million, AGR%, CAGR%), Tariff Impact: L- Shaped Recovery Scenario
  • Table 6 Precision Medicine Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 7 Therapeutics Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 8 Therapeutics Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 9 Monoclonal Antibodies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 10 Inhibitor Drugs Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 11 Cell & Gene Therapies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 12 RNA-Based Therapies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 13 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 14 Diagnostics Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 15 Diagnostic Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 16 Genetic Tests Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 17 Biomarker-based Tests Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 18 Other Diagnostic Tests Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 19 Precision Medicine Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 20 Oncology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 21 Immunology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 22 CNS Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 23 Respiratory Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 24 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 25 Precision Medicine Market Forecast by Technology, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 26 Gene Sequencing Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 27 Drug Discovery Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 28 Big Data Analytics Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 29 Companion Diagnostics Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 30 Bioinformatics Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 31 Other Technologies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 32 Precision Medicine Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 33 Hospitals Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 34 Diagnostic Centres Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 35 Research & Academic Institutes Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 36 Other End-users Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 37 Precision Medicine Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 38 North America Precision Medicine Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 39 North America Precision Medicine Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 40 North America Therapeutics Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 41 North America Diagnostics Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 42 North America Precision Medicine Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 43 North America Precision Medicine Market Forecast by Technology, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 44 North America Precision Medicine Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 45 U.S. Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 46 Canada Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 47 Europe Precision Medicine Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 48 Europe Precision Medicine Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 49 Europe Therapeutics Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 50 Europe Diagnostics Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 51 Europe Precision Medicine Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 52 Europe Precision Medicine Market Forecast by Technology, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 53 Europe Precision Medicine Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 54 Germany Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 55 UK Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 56 France Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 57 Italy Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 58 Spain Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 59 Russia Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 60 Netherlands Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 61 Denmark Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 62 Rest of Europe Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 63 Asia Pacific Precision Medicine Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 64 Asia Pacific Precision Medicine Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 65 Asia Pacific Therapeutics Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 66 Asia Pacific Diagnostics Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 67 Asia Pacific Precision Medicine Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 68 Asia Pacific Precision Medicine Market Forecast by Technology, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 69 Asia Pacific Precision Medicine Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 70 Japan Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 71 China Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 72 India Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 73 Australia Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 74 South Korea Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 75 Singapore Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 76 Thailand Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 77 Rest of Asia Pacific Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 78 Latin America Precision Medicine Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 79 Latin America Precision Medicine Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 80 Latin America Therapeutics Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 81 Latin America Diagnostics Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 82 Latin America Precision Medicine Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 83 Latin America Precision Medicine Market Forecast by Technology, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 84 Latin America Precision Medicine Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 85 Brazil Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 86 Mexico Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 87 Argentina Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 88 Colombia Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 89 Rest of Latin America Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 90 MEA Precision Medicine Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 91 MEA Precision Medicine Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 92 MEA Therapeutics Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 93 MEA Diagnostics Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 94 MEA Precision Medicine Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 95 MEA Precision Medicine Market Forecast by Technology, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 96 MEA Precision Medicine Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 97 GCC Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 98 South Africa Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 99 Egypt Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 100 Rest of MEA Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 101 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 102 Pfizer Inc.: Product Benchmarking
  • Table 103 Pfizer Inc: Strategic Outlook
  • Table 104 Qiagen: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 105 Qiagen: Product Benchmarking
  • Table 106 Qiagen: Strategic Outlook
  • Table 107 Quest Diagnostics Incorporated: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 108 Quest Diagnostics Incorporated: Product Benchmarking
  • Table 109 Quest: Strategic Outlook
  • Table 110 Agilent Technologies Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 111 Agilent Technologies Inc.: Product Benchmarking
  • Table 112 Agilent Technologies: Strategic Outlook
  • Table 113 Illumina, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 114 Illumina, Inc.: Product Benchmarking
  • Table 115 Illumina: Strategic Outlook
  • Table 116 Novartis AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 117 Novartis AG: Product Benchmarking
  • Table 118 Novartis: Strategic Outlook
  • Table 119 bioMerieux SA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 120 bioMerieux SA: Product Benchmarking
  • Table 121 bioMerieux SA: Strategic Outlook
  • Table 122 F. Hoffmann-La Roche Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 123 F. Hoffmann-La Roche Ltd.: Product Benchmarking
  • Table 124 F. Hoffmann-La Roche Ltd: Strategic Outlook
  • Table 125 Abbott : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 126 Abbott: Product Benchmarking
  • Table 127 Abbott: Strategic Outlook
  • Table 128 Eli Lilly and Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 129 Eli Lilly and Company: Product Benchmarking
  • Table 130 Eli Lilly and Company: Strategic Outlook
  • Table 131 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 132 Thermo Fisher Scientific Inc.: Product Benchmarking
  • Table 133 Thermo Fisher Scientific: Strategic Outlook
  • Table 134 AstraZeneca: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 135 AstraZeneca: Product Benchmarking
  • Table 136 AstraZeneca: Strategic Outlook
  • Table 137 Myriad Genetics Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 138 Myriad Genetics Inc.: Product Benchmarking
  • Table 139 Biogen: Strategic Outlook
  • Table 140 GSK plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 141 GSK plc: Product Benchmarking
  • Table 142 GSK: Strategic Outlook
  • Table 143 Bristol-Myers Squibb Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 144 Bristol-Myers Squibb Company: Product Benchmarking
  • Table 145 Bristol-Myers Squibb Company: Strategic Outlook
  • Table 146 Danaher : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 147 Danaher: Product Benchmarking
  • Table 148 Danaher: Strategic Outlook
  • Table 149 Laboratory Corporation of America Holdings: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 150 Laboratory Corporation of America Holdings: Product Benchmarking
  • Table 151 Laboratory Corporation of America Holdings: Strategic Outlook
  • Table 152 GE HealthCare: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 153 GE HealthCare: Product Benchmarking
  • Table 154 GE Healthcare: Strategic Outlook
  • Table 155 Teva Pharmaceutical Industries Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 156 Teva Pharmaceutical Industries Ltd.: Product Benchmarking
  • Table 157 Teva: Strategic Outlook
  • Table 158 Bayer AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 159 Bayer AG: Product Benchmarking
  • Table 160 Bayer AG: Strategic Outlook
  • Table 161 Biogen: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 162 Biogen: Product Benchmarking
  • Table 163 Biogen: Strategic Outlook
  • Table 164 Johnson & Johnson: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 165 Johnson & Johnson: Product Benchmarking
  • Table 166 J&J: Strategic Outlook
  • Table 167 Abnova Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 168 Abnova Corporation: Product Benchmarking
  • Table 169 Abnova Corporation: Strategic Outlook
  • Table 170 Bruker Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 171 Bruker Corporation: Product Benchmarking
  • Table 172 Bruker Corporation: Strategic Outlook
  • Table 173 23andMe, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 174 23andMe, Inc.: Product Benchmarking
  • Table 175 23andMe, Inc.: Strategic Outlook
  • Table 176 Tempus: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 177 Tempus: Product Benchmarking
  • Table 178 Tempus: Strategic Outlook
  • Table 179 GRAIL Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 180 GRAIL Inc.: Product Benchmarking
  • Table 181 GRAIL Inc.: Strategic Outlook
  • Table 182 Adaptive Biotechnologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 183 Adaptive Biotechnologies: Product Benchmarking
  • Table 184 Adaptive Biotechnologies: Strategic Outlook
  • Table 185 Regeneron Pharmaceuticals: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 186 Regeneron Pharmaceuticals: Product Benchmarking
  • Table 187 Regeneron Pharmaceuticals: Strategic Outlook

List of Figures

  • Figure 1 Precision Medicine Market Segmentation
  • Figure 2 Precision Medicine Market Attractiveness Index by Region
  • Figure 3 Precision Medicine Market by Product Type: Market Attractiveness Index
  • Figure 4 Precision Medicine Market by Application: Market Attractiveness Index
  • Figure 5 Precision Medicine Market by Technology: Market Attractiveness Index
  • Figure 6 Precision Medicine Market by End-users: Market Attractiveness Index
  • Figure 7 Precision Medicine Market: Market Dynamics
  • Figure 1 Healthcare Cold Chain Logistics Market: Impact Analysis
  • Figure 8 Precision Medicine Market by Region, 2025-2035 (US$ Million, AGR %), Tariff Impact: V-Shaped Recovery Scenario
  • Figure 9 Precision Medicine Market by Region, 2025-2035 (US$ Million, AGR %), Tariff Impact: U-Shaped Recovery Scenario
  • Figure 10 Precision Medicine Market by Region, 2025-2035 (US$ Million, AGR %), Tariff Impact: L-Shaped Recovery Scenario
  • Figure 11 Short Term & Long Term Planning
  • Figure 12 Impact of U.S. and China Trade War
  • Figure 13 Most Impacted Countries
  • Figure 14 Global Market Tariff Sensitivity and Margin Pressure Analysis
  • Figure 15 Precision Medicine Market: Porter's Five Forces Analysis
  • Figure 16 Global Precision Medicine Market: SWOT Analysis
  • Figure 17 Precision Medicine Market: PEST Analysis
  • Figure 18 Precision Medicine Market Attractiveness Index by Product Type
  • Figure 19 Precision Medicine Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 20 Precision Medicine Market Share Forecast by Product Type, 2025, 2030, 2035 (%)
  • Figure 21 Therapeutics Market Attractiveness Index by Type
  • Figure 22 Therapeutics Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 23 Therapeutics Market Share Forecast by Type, 2025, 2030, 2035 (%)
  • Figure 24 Therapeutics Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 25 Therapeutics Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 26 Monoclonal Antibodies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 27 Monoclonal Antibodies Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 28 Inhibitor Drugs Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 29 Inhibitor Drugs Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 30 Cell & Gene Therapies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 31 Cell & Gene Therapies Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 32 RNA-Based Therapies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 33 RNA-Based Therapies Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 34 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 35 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 36 Diagnostics Market Attractiveness Index by Type
  • Figure 37 Diagnostics Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 38 Diagnostics Market Share Forecast by Type, 2025, 2030, 2035 (%)
  • Figure 39 Diagnostic Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 40 Diagnostic Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 41 Genetic Tests Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 42 Genetic Tests Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 43 Biomarker-based Tests Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 44 Biomarker-based Tests Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 45 Other Diagnostic Tests Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 46 Other Diagnostic Tests Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 47 Precision Medicine Market Attractiveness Index by Application
  • Figure 48 Precision Medicine Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
  • Figure 49 Precision Medicine Market Share Forecast by Application, 2025, 2030, 2035 (%)
  • Figure 50 Oncology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 51 Oncology Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 52 Immunology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 53 Immunology Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 54 CNS Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 55 CNS Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 56 Respiratory Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 57 Respiratory Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 58 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 59 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 60 Precision Medicine Market Attractiveness Index by Technology
  • Figure 61 Precision Medicine Market Forecast by Technology, 2025-2035 (US$ Billion, AGR %)
  • Figure 62 Precision Medicine Market Share Forecast by Technology, 2025, 2030, 2035 (%)
  • Figure 63 Gene Sequencing Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 64 Gene Sequencing Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 65 Drug Discovery Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 66 Drug Discovery Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 67 Big Data Analytics Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 68 Big Data Analytics Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 69 Companion Diagnostics Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 70 Companion Diagnostics Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 71 Bioinformatics Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 72 Bioinformatics Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 73 Other Technologies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 74 Other Technologies Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 75 Precision Medicine Market Attractiveness Index by End-users
  • Figure 76 Precision Medicine Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
  • Figure 77 Precision Medicine Market Share Forecast by End-users, 2025, 2030, 2035 (%)
  • Figure 78 Hospitals Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 79 Hospitals Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 80 Diagnostic Centres Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 81 Diagnostic Centres Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 82 Research & Academic Institutes Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 83 Research & Academic Institutes Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 84 Other End-users Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 85 Other End-users Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 86 Precision Medicine Market Forecast by Region 2025 and 2035 (Revenue, CAGR%)
  • Figure 87 Precision Medicine Market Share Forecast by Region 2025, 2030, 2035 (%)
  • Figure 88 Precision Medicine Market by Region, 2025-2035 (US$ Bn)
  • Figure 89 North America Precision Medicine Market Attractiveness Index
  • Figure 90 North America Precision Medicine Market by Region, 2025, 2030 & 2035 (US$ Billion)
  • Figure 91 North America Precision Medicine Market Forecast by Country, 2025-2035 (US$ billion)
  • Figure 92 North America Precision Medicine Market Share Forecast by Country, 2025 & 2035 (%)
  • Figure 93 North America Precision Medicine Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 94 North America Precision Medicine Market Share Forecast by Product Type, 2025 & 2035 (%)
  • Figure 95 North America Therapeutics Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 96 North America Therapeutics Market Share Forecast by Type, 2025 & 2035 (%)
  • Figure 97 North America Diagnostics Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 98 North America Diagnostics Market Share Forecast by Type, 2025 & 2035 (%)
  • Figure 99 North America Precision Medicine Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
  • Figure 100 North America Precision Medicine Market Share Forecast by Application, 2025 & 2035 (%)
  • Figure 101 North America Precision Medicine Market Forecast by Technology, 2025-2035 (US$ Billion, AGR %)
  • Figure 102 North America Precision Medicine Market Share Forecast by Technology, 2025 & 2035 (%)
  • Figure 103 North America Precision Medicine Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
  • Figure 104 North America Precision Medicine Market Share Forecast by End-users, 2025 & 2035 (%)
  • Figure 105 U.S. Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 106 Canada Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 107 Europe Precision Medicine Market Attractiveness Index
  • Figure 108 Europe Precision Medicine Market by Region, 2025, 2030 & 2035 (US$ Billion)
  • Figure 109 Europe Precision Medicine Market Forecast by Country, 2025-2035 (US$ Billion)
  • Figure 110 Europe Precision Medicine Market Share Forecast by Country, 2025 & 2035 (%)
  • Figure 111 Europe Precision Medicine Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 112 Europe Precision Medicine Market Share Forecast by Product Type, 2025 & 2035 (%)
  • Figure 113 Europe Therapeutics Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 114 Europe Therapeutics Market Share Forecast by Type, 2025 & 2035 (%)
  • Figure 115 Europe Diagnostics Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 116 Europe Diagnostics Market Share Forecast by Type, 2025 & 2035 (%)
  • Figure 117 Europe Precision Medicine Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
  • Figure 118 Europe Precision Medicine Market Share Forecast by Application, 2025 & 2035 (%)
  • Figure 119 Europe Precision Medicine Market Forecast by Technology, 2025-2035 (US$ Billion, AGR %)
  • Figure 120 Europe Precision Medicine Market Share Forecast by Technology, 2025 & 2035 (%)
  • Figure 121 Europe Precision Medicine Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
  • Figure 122 Europe Precision Medicine Market Share Forecast by End-users, 2025 & 2035 (%)
  • Figure 123 Germany Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 124 UK Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 125 France Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 126 Italy Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 127 Spain Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 128 Russia Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 129 Netherlands Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 130 Denmark Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 131 Rest of Europe Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 132 Asia Pacific Precision Medicine Market Attractiveness Index
  • Figure 133 Asia Pacific Precision Medicine Market by Region, 2025, 2030 & 2035 (US$ Billion)
  • Figure 134 Europe Precision Medicine Market Forecast by Country, 2025-2035 (US$ Billion)
  • Figure 135 Europe Precision Medicine Market Share Forecast by Country, 2025 & 2035 (%)
  • Figure 136 Asia Pacific Precision Medicine Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 137 Asia Pacific Precision Medicine Market Share Forecast by Product Type, 2025 & 2035 (%)
  • Figure 138 Asia Pacific Therapeutics Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 139 Asia Pacific Therapeutics Market Share Forecast by Type, 2025 & 2035 (%)
  • Figure 140 Asia Pacific Diagnostics Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 141 Asia Pacific Diagnostics Market Share Forecast by Type, 2025 & 2035 (%)
  • Figure 142 Asia Pacific Precision Medicine Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
  • Figure 143 Asia Pacific Precision Medicine Market Share Forecast by Application, 2025 & 2035 (%)
  • Figure 144 Asia Pacific Precision Medicine Market Forecast by Technology, 2025-2035 (US$ Billion, AGR %)
  • Figure 145 Asia Pacific Precision Medicine Market Share Forecast by Technology, 2025 & 2035 (%)
  • Figure 146 Asia Pacific Precision Medicine Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
  • Figure 147 Asia Pacific Precision Medicine Market Share Forecast by End-users, 2025 & 2035 (%)
  • Figure 148 Japan Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 149 China Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 150 India Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 151 Australia Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 152 South Korea Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 153 Singapore Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 154 Thailand Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 155 Rest of Asia Pacific Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 156 Latin America Precision Medicine Market Attractiveness Index
  • Figure 157 Latin America Precision Medicine Market by Region, 2025, 2030 & 2035 (US$ Billion)
  • Figure 158 Latin America Precision Medicine Market Forecast by Country, 2025-2035 (US$ billion)
  • Figure 159 Latin America Precision Medicine Market Share Forecast by Country, 2025 & 2035 (%)
  • Figure 160 Latin America Precision Medicine Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 161 Latin America Precision Medicine Market Share Forecast by Product Type, 2025 & 2035 (%)
  • Figure 162 Latin America Therapeutics Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 163 Latin America Therapeutics Market Share Forecast by Type, 2025 & 2035 (%)
  • Figure 164 Latin America Diagnostics Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 165 Latin America Diagnostics Market Share Forecast by Type, 2025 & 2035 (%)
  • Figure 166 Latin America Precision Medicine Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
  • Figure 167 Latin America Precision Medicine Market Share Forecast by Application, 2025 & 2035 (%)
  • Figure 168 Latin America Precision Medicine Market Forecast by Technology, 2025-2035 (US$ Billion, AGR %)
  • Figure 169 Latin America Precision Medicine Market Share Forecast by Technology, 2025 & 2035 (%)
  • Figure 170 Latin America Precision Medicine Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
  • Figure 171 Latin America Precision Medicine Market Share Forecast by End-users, 2025 & 2035 (%)
  • Figure 172 Brazil Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 173 Mexico Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 174 Argentina Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 175 Colombia Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 176 Rest of Latin America Precision Medicine Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 177 MEA Precision Medicine Market Attractiveness Index
  • Figure 178 MEA Precision Medicine Market by Region, 2025, 2030 & 2035 (US$ Billion)
  • Figure 179 MEA Precision Medicine Market Forecast by Country, 2025-2035 (US$ billion)
  • Figure 180 MEA Precision Medicine Market Share Forecast by Country, 2025 & 2035 (%)
  • Figure 181 MEA Precision Medicine Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 182 MEA Precision Medicine Market Share Forecast by Product Type, 2025 & 2035 (%)
  • Figure 183 MEA Therapeutics Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 184 MEA Therapeutics Market Share Forecast by Type, 2025 & 2035 (%)
  • Figure 185 MEA Diagnostics Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 186 MEA Diagnostics Market Share Forecast by Type, 2025 & 2035 (%)
  • Figure 187 MEA Precision Medicine Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!